Počet záznamov: 1
enoxaparín
SYS d017984 LBL 00000nz--a2200000o--4500 005 20250606213708.9 008 930604|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D09.698.373.400.300.200 066 $a 01 $c 03 150 $a enoxaparín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 550 $7 sllk_us_auth*d000925 $Y Anticoagulants $w P $a antikoagulanciá 550 $7 sllk_us_auth*d005343 $Y Fibrinolytic Agents $w P $a fibrinolytiká 665 $a 94; was heading 1992-93; was see HEPARIN, LOW-MOLECULAR-WEIGHT 1990-91 $2 eng 680 9-
$i Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) $2 eng 750 -2
$a Enoxaparin $2 eng 980 $x M
Počet záznamov: 1